BioNTech SE (BNTX) Balance Sheet

NASDAQ: BNTXAssets, liabilities, debt and equity over 10 years.

BNTX balance sheet, 2025

December 31, 2025 · euros

€21.98B assets = €2.76B liabilities + €19.22B equity

What it owns€21.98BCash & ST investments: €14.83B (67.5%)Cash & ST investments€14.83B · 67%Receivables: €984.5M (4.5%)Inventory: €110.7M (0.5%)Other current: €210.7M (1.0%)PP&E: €1.29B (5.9%)PP&E €1.29BGoodwill & intangibles: €1.97B (9.0%)€1.97BLT investments: €2.55B (11.6%)LT investments€2.55B · 12%Other non-current: €21.7M (0.1%)=How it is financed€21.98BCurrent liabilities: €2.14B (9.7%)Current liabilities €2.14BLong-term debt: €215.2M (1.0%)Other LT liabilities: €406.6M (1.9%)Shareholders’ equity: €19.22B (87.4%)Shareholders’ equity€19.22B · 87%

Both columns are drawn to the same scale: what BNTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BNTX financial health

Current ratio7.54
Comfortable · current assets cover current liabilities 7.54×
Debt / equity0.01
Low leverage · €0.01 of debt for each $1 of equity
Equity / assets87.4%
Equity-funded · of assets funded by shareholders
Cash / debt5,549.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles9.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BNTX balance sheet trends, 2016–2025

MetricTrendThenLatestChange
Total assets€390.0M2016€21.98B2025+56.5%/yr
Total liabilities€358.1M2016€2.76B2025+25.5%/yr
Shareholders’ equity€30.5M2016€19.22B2025+104.7%/yr
Cash & short-term investments€305.2M2016€14.83B2025+54.0%/yr
Total debt€26.7M2016€267.3M2025+29.2%/yr
Net cash (debt)€278.5M2016€14.57B2025+€14.3B
Working capital€261.5M2016€14.00B2025+€13.7B
Current ratio5.6220167.542025+1.92
Debt / equity0.8820160.012025−0.86
Shares outstanding226.9M2017241.7M2025+0.8%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BNTX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BNTX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BNTX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BNTX balance sheet in euros

2025202420232022202120202019201820172016
Assets
Cash & short-term investments€14.83B€16.78B€16.55B€14.06B€2.07B€1.35B€520.8M€411.8M€172.4M€305.2M
Cash & equivalents€7.67B€9.76B€11.66B€13.88B€1.69B€1.21B€519.1M€411.5M€172.1M€303.7M
Short-term investments€7.16B€7.02B€4.89B€189.4M€381.6M€137.2M€1.7M€336,000€246,000€1.5M
Receivables€984.5M€1.52B€2.34B€7.15B€12.38B€165.5M€20.2M€28.4M€4.6M€6.0M
Inventory€110.7M€283.3M€357.7M€439.6M€502.5M€64.1M€11.7M€5.8M€3.9M€3.3M
Other current assets€210.7M€212.7M€280.9M€271.9M€113.4M€89.9M€7.4M€2.9M€8.8M€3.7M
Total current assets€16.14B€18.80B€19.53B€21.92B€15.07B€1.67B€560.2M€449.0M€189.6M€318.1M
Property, plant & equipment (net)€1.29B€1.18B€971.6M€821.1M€520.4M€326.0M€148.1M€116.0M€101.5M€60.5M
Goodwill & intangible assets€1.97B€1.17B€1.17B€219.7M€202.4M€157.5M€89.4M€88.0M€83.5M€11.2M
Long-term investments€2.55B€1.25B€1.18B€80.2M€21.3M€0€0€18,000€19,000€66,000
Other non-current assets€21.7M€117.8M€164.7M€236.1M€14.4M€168.2M€2,000€0€0€76,000
Total assets€21.98B€22.53B€23.01B€23.28B€15.83B€2.32B€797.6M€653.0M€374.7M€390.0M
Liabilities
Accounts payable€534.7M€426.7M€354.0M€204.1M€160.0M€102.3M€20.5M€41.7M€52.5M€6.2M
Short-term debt€52.2M€39.5M€28.1M€36.0M€129.9M€9.1M€7.6M€6.2M€19.4M€3.0M
Deferred revenue€754.6M€294.9M€353.3M€77.1M€186.1M€391.5M€93.6M€66.0M€77.3M€33.5M
Total current liabilities€2.14B€2.52B€2.07B€2.95B€3.48B€606.0M€138.1M€126.1M€158.5M€56.6M
Long-term debt€215.2M€214.7M€191.0M€176.2M€171.6M€231.0M€68.9M€5.6M€0€0
Lease obligations——————€0€0€0€0
Other long-term liabilities€406.6M€380.7M€498.9M€96.7M€283.9M€109.8M€97.1M€254.3M€264.4M€301.5M
Total liabilities€2.76B€3.12B€2.76B€3.22B€3.94B€946.8M€304.2M€386.0M€422.9M€358.1M
Shareholders' equity
Common stock & paid-in capital€258.9M€248.6M€248.6M€248.6M€246.3M€246.3M€232.3M€193.3M€166.8M€3.3M
Retained earnings (deficit)€17.95B€19.10B€19.76B€18.83B€9.88B−€409.6M−€424.8M−€245.8M−€197.8M−€112.1M
Treasury stock——————−€5.5M€0€0€0
Accumulated other comprehensive income−€1.46B−€1.33B−€984.6M−€848.9M€93.9M€1.54B€691.5M€318.6M−€18.3M€139.3M
Minority interest——————€0€0€0€0
Total shareholders' equity€19.22B€19.41B€20.25B€20.06B€11.89B€1.37B€493.5M€266.2M−€49.3M€30.5M
Key figures
Total debt€267.3M€254.2M€219.1M€212.2M€301.5M€240.1M€76.5M€54.2M€50.3M€26.7M
Net cash (debt)€14.57B€16.53B€16.33B€13.85B€1.77B€1.11B€444.3M€357.6M€122.0M€278.5M
Working capital€14.00B€16.28B€17.46B€18.97B€11.59B€1.06B€422.0M€322.8M€31.1M€261.5M
Tangible book value€17.24B€18.24B€19.08B€19.84B€11.69B€1.21B€404.1M€178.1M−€132.8M€19.3M
Shares outstanding241.7M240.4M242.7M249.8M259.7M248.5M211.5M226.9M226.9M—
Current ratio7.547.459.437.434.332.754.053.561.205.62
Quick ratio7.397.269.127.194.152.503.923.491.125.49
Debt / equity0.010.010.010.010.030.180.160.20—0.88
Equity / assets87.4%86.2%88.0%86.2%75.1%59.2%61.9%40.8%−13.2%7.8%

Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported (latest annual report filed March 10, 2026); data from EODHD.

BNTX financial position

At the end of fiscal 2025 (December 31, 2025), BioNTech had total assets of €22.0 billion (down 2.4% from a year earlier), total liabilities of €2.8 billion and shareholders' equity of €19.2 billion. It held €14.8 billion in cash and short-term investments against €267.3 million of debt, a net cash position of €14.6 billion. Its current ratio was 7.54. In the latest quarter (ended June 30, 2026) total assets were €20.3 billion and equity €17.8 billion.

Related: BNTX income statement, BNTX cash flow statement, BNTX key metrics. See the BNTX stock overview for the latest quote and news.

BNTX balance sheet FAQ

What are BioNTech's total assets?

BioNTech reported total assets of €22.0 billion at the end of fiscal 2025 (December 31, 2025), compared with €22.5 billion a year earlier.

How much debt does BioNTech have?

BioNTech had €267.3 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.01.

How much cash does BioNTech have?

BioNTech held €14.8 billion in cash and short-term investments at the end of fiscal 2025; with €267.3 million of debt that is net cash of €14.6 billion.

What is BioNTech's book value?

BioNTech's shareholders' equity (book value) was €19.2 billion at the end of fiscal 2025.

What is BioNTech's current ratio?

BioNTech had current assets of €16.1 billion and current liabilities of €2.1 billion, a current ratio of 7.54 (it can cover its short-term obligations).

How much goodwill does BioNTech have?

BioNTech carried €2.0 billion of goodwill and intangible assets, 9.0% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet